OtsukaLtd. 

$33.88
87
+$0.20+0.59% 19:59 Today

Statistics

Day High
33.91
Day Low
33.87
52W High
37.52
52W Low
21.68
Volume
767
Avg. Volume
43,981
Mkt Cap
18.4B
P/E Ratio
16.53
Dividend Yield
1.35%
Dividend
0.46

Upcoming

Dividends

1.35%Dividend Yield
Apr 26
$0.22
Sep 25
$0.23
Apr 25
$0.20
Sep 24
$0.21
Apr 24
$0.20
10Y Growth
-7.24%
5Y Growth
-12.68%
3Y Growth
-15.79%
1Y Growth
-51.75%

Earnings

31JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0.78
1.11
1.45
1.78
Expected EPS
0.957258407963
Actual EPS
N/A

Financials

14.78%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
16.96BRevenue
2.51BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OTSKY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap137.76B
Pfizer is a global pharmaceutical company that competes with Otsuka in various therapeutic areas, including psychiatric and neurological disorders.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its pharmaceutical segment, competes directly with Otsuka in the development and marketing of drugs for various conditions.
Novartis
NVS
Mkt Cap293.94B
Novartis is a leading healthcare company that competes with Otsuka in several areas, including neuroscience and digital health solutions.
GSK
GSK
Mkt Cap105.71B
GlaxoSmithKline competes with Otsuka in the pharmaceutical sector, particularly in the development of medications for psychiatric conditions.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie competes with Otsuka in the neuroscience domain, particularly in the development of treatments for psychiatric disorders.
Merck
MRK
Mkt Cap305.12B
Merck & Co. competes with Otsuka in the healthcare sector, focusing on pharmaceuticals that address critical areas of health.
Takeda Pharmaceutical
TAK
Mkt Cap52.88B
Takeda Pharmaceutical Company competes with Otsuka, especially in Japan and in the field of neuroscience, sharing a similar market focus.
Rogers
ROG
Mkt Cap2.45B
Roche Holding AG competes with Otsuka in the pharmaceutical and diagnostics sectors, particularly in areas like personalized healthcare.
Astrazeneca
AZN
Mkt Cap266.15B
AstraZeneca competes with Otsuka in various therapeutic areas, including the development of treatments for diseases in oncology and cardiovascular.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol Myers Squibb competes with Otsuka in the pharmaceutical sector, particularly in the development of innovative medicines for serious diseases.

About

Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.
Show more...
CEO
Mr. Makoto Inoue
Employees
37758
Country
Japan
ISIN
US6891641010

Listings

0 Comments

Share your thoughts

FAQ

What is OtsukaLtd. stock price today?
The current price of OTSKY is $33.88 USD — it has increased by +0.59% in the past 24 hours. Watch OtsukaLtd. stock price performance more closely on the chart.
What is OtsukaLtd. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange OtsukaLtd. stocks are traded under the ticker OTSKY.
Is OtsukaLtd. stock price growing?
OTSKY stock has fallen by -1.48% compared to the previous week, the month change is a +1.47% rise, over the last year OtsukaLtd. has showed a +52.57% increase.
What is OtsukaLtd. market cap?
Today OtsukaLtd. has the market capitalization of 18.4B
When is the next OtsukaLtd. earnings date?
OtsukaLtd. is going to release the next earnings report on July 31, 2026.
What were OtsukaLtd. earnings last quarter?
OTSKY earnings for the last quarter are 1.17 USD per share, whereas the estimation was 0.86 USD resulting in a +36.72% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is OtsukaLtd. revenue for the last year?
OtsukaLtd. revenue for the last year amounts to 16.96B USD.
What is OtsukaLtd. net income for the last year?
OTSKY net income for the last year is 2.51B USD.
Does OtsukaLtd. pay dividends?
Yes, OTSKY dividends are paid semi-annual. The last dividend per share was 0.22 USD. As of today, Dividend Yield (FWD)% is 1.35%.
How many employees does OtsukaLtd. have?
As of July 16, 2026, the company has 37,758 employees.
In which sector is OtsukaLtd. located?
OtsukaLtd. operates in the Health & Wellness sector.
When did OtsukaLtd. complete a stock split?
OtsukaLtd. has not had any recent stock splits.
Where is OtsukaLtd. headquartered?
OtsukaLtd. is headquartered in Chiyoda, Japan.